Hussain Nasir, Gersh Bernard J, Gonzalez Carta Karina, Sydó Nóra, Lopez-Jimenez Francisco, Kopecky Stephen L, Thomas Randal J, Asirvatham Samuel J, Allison Thomas G
Mayo Clinic, Rochester, Minnesota.
Mayo Clinic, Rochester, Minnesota; Heart and Vascular Center, Semmelweis University, Budapest, Hungary.
Am J Cardiol. 2018 Jan 1;121(1):41-49. doi: 10.1016/j.amjcard.2017.09.021. Epub 2017 Nov 13.
Benefits of cardiorespiratory fitness on cardiovascular health are well recognized, but the impact on incidence of atrial fibrillation (AF) and stroke, and, particularly, risk of stroke and mortality in patients with AF is less clear. From 1993 to 2010, patients referred for a treadmill exercise test (TMET) at the Mayo Clinic Rochester, MN, were retrospectively identified (N = 76,857). From this, 14,094 local residents were selected. Exclusions were age <18 years; history of heart failure, structural or valvular heart disease, AF or flutter, or stroke. Subjects were divided into 4 groups at baseline based on quartiles of functional aerobic capacity (FAC) and followed through January 2016. The final study cohort included 12,043 patients. During median follow-up of 14 (9 to 17) years, 1,222 patients developed incident AF, 1,128 developed stroke, and 1,590 patients died. Each 10% increase in FAC was associated with decreased risk of incident AF, stroke, and mortality by 7% (0.93 [0.91 to 0.96, p < 0.001]), 8% (0.92 [0.89 to 0.94, p < 0.001]), and 16% (0.84 [0.82 to 0.86, p < 0.001]), respectively. In patients who developed incident AF with baseline FAC <75% versus ≥105%, risks of both stroke (1.40 [1.04 to 1.90, p = 0.01]) and mortality (3.20 [2.11 to 4.58, p < 0.001]) were significantly higher. In conclusion, better cardiorespiratory fitness is associated with lower risk of incident AF, stroke, and mortality. Similarly, risk of stroke and mortality in patients with AF is also inversely associated with cardiorespiratory fitness.
心肺适能对心血管健康的益处已得到充分认可,但对心房颤动(AF)和中风发病率的影响,尤其是对AF患者中风风险和死亡率的影响尚不清楚。1993年至2010年,对明尼苏达州罗切斯特市梅奥诊所接受跑步机运动试验(TMET)的患者进行了回顾性识别(N = 76,857)。从中选取了14,094名当地居民。排除标准为年龄<18岁;有心力衰竭、结构性或瓣膜性心脏病、AF或扑动或中风病史。受试者在基线时根据功能性有氧能力(FAC)四分位数分为4组,并随访至2016年1月。最终研究队列包括12,043名患者。在14(9至17)年的中位随访期间,1,222名患者发生了新发AF,1,128名患者发生了中风,1,590名患者死亡。FAC每增加10%,新发AF、中风和死亡率的风险分别降低7%(0.93 [0.91至0.96,p < 0.001])、8%(0.92 [0.89至0.94,p < 0.001])和16%(0.84 [0.82至0.86,p < 0.001])。在基线FAC<75%与≥105%的新发AF患者中,中风风险(1.40 [1.04至1.90,p = 0.01])和死亡率(3.20 [2.11至4.58,p < 0.001])均显著更高。总之,更好的心肺适能与更低的新发AF、中风和死亡率风险相关。同样,AF患者的中风和死亡率风险也与心肺适能呈负相关。